Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer

NCT00083031 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: bevacizumab
DRUG: cyclophosphamide
DRUG: methotrexate

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]